MedPath

Dextran

Generic Name
Dextran
Brand Names
Bion Tears, Colirio Ocusan, Genteal Tears, Genteal Tears Mild, Tears Naturale, Tears Renewed
Drug Type
Small Molecule
CAS Number
9004-54-0

Overview

Dextran is a polysaccharide that differs from others in that its glucose units are joined together 1:6 glucoside links. The main chain of glucose has short branches at frequent intervals which are probably joined by 1:3 and 1:4 glucoside links. The chains can be composed of about 200,000 glucose units. Many bacteria, like Leuconostoc, can synthesize dextran from sucrose, and this activity is used commercially to obtain dextran. Dextran 40 is a sterile, nonpyrogenic preparation of low molecular weight dextran (average mol. wt. 40,000) in 5% Dextrose Injection or 0.9% Sodium Chloride Injection. It is administered by intravenous infusion. Dextran 75 is a complex branched glucan with an average molecular weight 75000 Daltons. It is produced from certain bacteria that with α-1,6 glycosidic linkages between glucose molecules and α-1,3 linkages between branches. When labelled with technetium Tc99m, dextran 75 is intravenously administered as an imaging agent to detect and diagnose conditions in the vascular compartment such as pericardial effusion or ventricular aneurysm.

Indication

Dextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis. Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.

Associated Conditions

  • Blood Circulation Disorder
  • Capillary disorder
  • Dry Eyes
  • Ocular Irritation
  • Pulmonary Embolism
  • Pulmonary Embolism caused by procedures associated with a high incidence of thromboembolic complications
  • Shock
  • Thrombosis
  • Venous Thrombosis (Disorder)
  • Venous Thrombosis caused by procedures associated with a high incidence of thromboembolic complications

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2022/09/07
N/A
ENROLLING_BY_INVITATION
2022/04/06
Phase 4
Completed
Andover Research Eye Institute
2022/03/04
Phase 4
Completed
Andover Research Eye Institute
2021/08/17
N/A
Recruiting
2018/02/15
Not Applicable
UNKNOWN
LanZhou University
2017/07/07
Not Applicable
Completed
Huaxia Eye Hospital Group
2017/03/03
Phase 2
Completed
2017/02/23
Not Applicable
UNKNOWN
Tung Wah Hospital
2016/12/14
Not Applicable
UNKNOWN
Sun Yat-sen University
2016/08/11
Phase 1
Completed
Joseph B. Ciolino, MD

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Hospira, Inc.
0409-7419
INTRAVENOUS
10 g in 100 mL
2/15/2023
Hospira, Inc.
0409-7418
INTRAVENOUS
10 g in 100 mL
2/15/2023
DLC Laboratories, Inc.
24286-1575
OPHTHALMIC
1 mg in 1 mL
4/18/2025
Preferred PHarmaceuticals Inc.
68788-8635
OPHTHALMIC
0.1 g in 100 mL
5/7/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Dextran 20 Sodium Chloride Injection
国药准字H13023198
化学药品
注射剂
7/22/2020
Dextran 20 Sodium Chloride Injection
国药准字H20103165
化学药品
注射剂
5/6/2020
Dextran 20 Sodium Chloride Injection
国药准字H14020772
化学药品
注射剂
6/11/2020
Dextran 20 Sodium Chloride Injection
国药准字H14020773
化学药品
注射剂
6/12/2020
Dextran 20 Sodium Chloride Injection
国药准字H14020825
化学药品
注射剂
3/9/2020
Dextran 20 Sodium Chloride Injection
国药准字H20113421
化学药品
注射剂
4/7/2021
Compound Dextran 70 Eye Drops
国药准字H20093918
化学药品
眼用制剂
2/21/2020
Compound Dextran 70 Eye Drops
国药准字H20045277
化学药品
眼用制剂
7/20/2020
Compound Dextran 70 Eye Drops
国药准字H20073639
化学药品
滴眼剂
8/4/2022
Dextran 70 and Glycerol Eye Drops
国药准字H20184022
化学药品
眼用制剂
12/17/2023

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath